共 99 条
[1]
Kushner FG(2009)2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 Guideline and 2007 Focused update) and ACC/ AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2271-306
[2]
Hand M(2008)Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2909-45
[3]
Smith SC(2008)Antithrombotic therapies in primary angioplasty: rationale, results and future directions Drugs 68 2325-44
[4]
Van de Werf F(2008)Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction Thromb Haemost 100 184-95
[5]
Bax J(2004)Bivalent direct thrombin inhibitors: hirudin and bivalirudin Best Pract Res Clin Haematol 17 105-25
[6]
Betriu A(2001)Bivalirudin versus heparin during coronary angioplasty for unstable or post-infarction angina: final report reanalysis of the Bivalirudin Angioplasty Study Am Heart J 142 952-9
[7]
De Luca G(2003)Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 853-63
[8]
Marino P(2007)Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial Lancet 369 907-19
[9]
De Luca G(2008)Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2218-30
[10]
Marino P(2010)Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention Eur Heart J 31 561-72